The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population The LINQ II system is a small (one-third the size of a AAA battery), wireless ICM ...
Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy “In the current COVID-19 environment, the LINQ II system offers patients a seamless way to experience ...
The U.S. Food and Drug Administration gave Minneapolis-based Medtronic 510(k) clearance for its Reveal LINQ Insertable Cardiac Monitoring system, according to a news release. At one-third the size of ...
Medtronic this week received regulatory approval for use of an implantable cardiac monitor in pediatric patients, giving doctors and parents greater peace of mind about the device's safety. On Tuesday ...
ISC23: Late-breaking results from STROKE AF study reinforce importance of long-term continuous cardiac monitoring in ischemic stroke patients Over the first year, 12.5%* of patients in the ICM arm had ...
DALLAS -- Long-term monitoring improved the detection of atrial fibrillation (Afib) after a large artery or small vessel stroke, a randomized trial showed. Among survivors of strokes attributed to ...
Medtronic plc got a thumbs up from the FDA for two Accurhythm algorithms to detect atrial fibrillation and asystole in patients who have heart rhythm abnormalities. The new artificial intelligence (AI ...
Jennifer Adamy, a 43-year-old cardiac nurse living in New Smyrna Beach, Florida, was very familiar with the signs of heart problems. So, when she started experiencing symptoms of irregular heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback